Cogstate

Cogstate is a neuroscience technology company specializing in digital cognitive assessment and brain health measurement. For more than 25 years, the company has partnered with biopharmaceutical organizations, academic institutions, and healthcare providers to deliver scientifically validated solutions that support clinical research, therapeutic development, and earlier insights into cognitive health.

Its comprehensive portfolio includes digital cognitive assessments, electronic clinical outcome assessment (eCOA) solutions, endpoint data quality assurance, centralized rater training and monitoring, remote patient assessments, scientific consulting, and healthcare cognitive screening tools. By combining neuroscience expertise, advanced technology, and operational excellence, Cogstate helps sponsors improve the quality and consistency of clinical trial data while enabling healthcare professionals to detect and monitor cognitive impairment with greater accuracy.

Operating as a virtual-first global organization with teams and offices across Australia, the United States, and the United Kingdom, Cogstate is committed to advancing brain health through innovation and evidence-based science. Through its validated assessment technologies and deep clinical expertise, the company empowers researchers and healthcare providers to accelerate the development of new therapies and improve cognitive health outcomes for patients worldwide.